| 0 (0%) | 09-27 11:10 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 198.35 | 1-year : | 231.67 |
| Resists | First : | 169.82 | Second : | 198.35 |
| Pivot price | 168.64  |
|||
| Supports | First : | 161.52 |
Second : | 156.39 |
| MAs | MA(5) : | 169.8 | MA(20) : | 166.18 |
| MA(100) : | 164.58 |
MA(250) : | 163.08 |
|
| MACD | MACD : | 2.2 |
Signal : | 1.9 |
| %K %D | K(14,3) : | 99.8 |
D(3) : | 99.8 |
| RSI | RSI(14): 71.8 | |||
| 52-week | High : | 169.83 | Low : | 128.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ LHCG ] has closed below upper band by 32.7%. Bollinger Bands are 0.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 170.21 - 171.04 | 171.04 - 171.72 |
| Low: | 167.43 - 168.6 | 168.6 - 169.55 |
| Close: | 168.19 - 169.94 | 169.94 - 171.36 |
Wed, 22 Feb 2023
$5.4 Billion LHC Group-Optum Deal Closes - Home Health Care News
Wed, 22 Feb 2023
UnitedHealth, LHC Group close $5.4B merger deal - Fierce Healthcare
Wed, 22 Feb 2023
[UPDATED] Optum Closes $5.4 Billion LHC Group Acquisition - Hospice News
Mon, 02 May 2022
LHC GROUP INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of LHC Group, Inc. - LHCG - FinancialContent
Tue, 29 Mar 2022
UnitedHealth to buy LHC Group for $5.4 billion in home healthcare push - Reuters
Tue, 29 Mar 2022
Optum takes M&A streak home - Axios
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 31 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 4.7 (%) |
| Held by Institutions | 87 (%) |
| Shares Short | 3,010 (K) |
| Shares Short P.Month | 2,650 (K) |
| EPS | 3.55 |
| EPS Est Next Qtrly | 0.62 |
| EPS Est This Year | 2.39 |
| EPS Est Next Year | 2.63 |
| Book Value (p.s.) | 49.09 |
| Profit Margin | 2.7 % |
| Operating Margin | 6 % |
| Return on Assets (ttm) | 3.1 % |
| Return on Equity (ttm) | 4.8 % |
| Qtrly Rev. Growth | 2 % |
| Gross Profit (p.s.) | 28.45 |
| Sales Per Share | 74.44 |
| EBITDA (p.s.) | 5.27 |
| Qtrly Earnings Growth | -36.5 % |
| Operating Cash Flow | -39 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | 47.69 |
| PEG Ratio | -21 |
| Price to Book value | 3.45 |
| Price to Sales | 2.28 |
| Price to Cash Flow | -136.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|